Literature DB >> 79142

Increased transport of (G-14C) cytidine into rat liver after administration of alpha-hexachlorocyclohexane.

J Seifert, E Buchar.   

Abstract

The transport of cytidine into liver over a wide dose range (0.003--100mumol per animal) proceeds as an nonsaturabel process. After the administration of alpha-hexachlorocyclohexane (alpha-HCH)1 the transport of (G-14C) cytidine is markedly activated if the concentration of nucleoside administered is low; the differences between the control and experimental group disappear after the administration of higher doses of the nucleoside. The incorporation of (G-14C) cytidine into RNA cytosine is enhanced after the administration of alpha-HCH. The degree of utilization of labeled cytidine for the RNA synthesis decreases in proportion to the logarithm of its dose, both in the control and in the experimental group. Increased transport of (G-14C)cytidine is observable even between the 4th and 6th day after the administration of a single dose of alpha-HCH.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79142     DOI: 10.1007/BF00496191

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Microsomal inducers of drug-metabolizing enzymes suppress cytidine nucleotide biosynthesis in rat liver.

Authors:  J Seifert; J Vácha
Journal:  Arch Biochem Biophys       Date:  1975-03       Impact factor: 4.013

2.  Inhibition of (6- 14 C) orotic acid incorporation into the cytosine moiety of the ribonucleic acid of rat liver cytoplasmic ribosomes after phenobarbital administration.

Authors:  J Seifert; J Vácha
Journal:  Mol Pharmacol       Date:  1973-03       Impact factor: 4.436

3.  Effects of cortisone on orotic acid transport and RNA synthesis in rat liver.

Authors:  F L Yu; P Feigelson
Journal:  Arch Biochem Biophys       Date:  1970-12       Impact factor: 4.013

4.  Rates of formation of blood-borne uridine and cytidine in dogs.

Authors:  J Tseng; J Barelkovski; E Gurpide
Journal:  Am J Physiol       Date:  1971-09

5.  Liver growth and mixed-function oxidase activity: dose-dependent stimulatory and inhibitory effects of alpha-hexachlorocyclohexane.

Authors:  R Schulte-Hermann; C Leberl; H Landgraf; W Koransky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  6-(14C)-orotate uptake and rna synthesis by liver from thyroidectomized rats treated with 3,5,3'-triiodo-1-thyronine (t3).

Authors:  A Viarengo; A Zoncheddu; R Accomando; M P Molinari
Journal:  Ital J Biochem       Date:  1975 May-Aug

7.  Studies on the in vitro turnover of histone acetyl groups and the increase of RNA synthesis in rat liver nuclei after in vivo application of alpha-hexachlorocyclohexane (alpha-HCH).

Authors:  H I Sarkander; W P Brade
Journal:  Biochem Pharmacol       Date:  1975-12-15       Impact factor: 5.858

8.  Sex-dependent differences in the biosynthesis of pyrimidine nucleotides in rat liver after repeated administration of alpha-hexachlorocyclohexane.

Authors:  J Seifert; J Vácha
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

9.  Transport changes rapidly initiated by serum addition to "contact inhibited" 3T3 cells.

Authors:  D D Cunningham; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

10.  Decreased utilization of [2-14C]orotic acid for the synthesis of cytidine nucleotides in rat liver after administration of alpha-hexachlorocyclohexane.

Authors:  J Seifert; J Vácha
Journal:  Toxicology       Date:  1977-04       Impact factor: 4.221

View more
  2 in total

1.  Biosynthesis of pyrimidine nucleotides and level of cytochrome P-450 in rat liver and kidney after clofibrate administration (an in vivo study).

Authors:  J Seifert; Z Machková
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Effect of clofibrate on DNA synthesis in rat liver and kidney.

Authors:  J Seifert; H Mostecká
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.